Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech
In a landmark collaboration, Opyl Limited announced a new six-month agreement with BioIntelect, a renowned Clinical Research Organisation (CRO) and strategic consulting firm in the life sciences industry. The partnership is set to revolutionise clinical trial outcomes through Opyl’s cutting-edge TrialKey platform, which offers data-driven biostatistical validation to optimise trial design. Key Points of the […]
